Variability of disease activity in patients treated with ranibizumab for neovascular age-related macular degeneration – (Eye 30, 1072 (August 2016))
Variability of disease activity in patients treated with ranibizumab for neovascular age-related macular degeneration Eye 30, 1072 (August 2016). doi:10.1038/eye.2016.97 Authors: P Enders, P Scholz, P S Muether & S Fauser
Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy – (Eye 30, 1077 (August 2016))
Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy Eye 30, 1077 (August 2016). doi:10.1038/eye.2016.95 Authors: F Ricci, M Parravano, F Regine, M Sciamanna, M Tedeschi, F Missiroli & M Varano
Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion – (Eye 30, 1084 (August 2016))
Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion Eye 30, 1084 (August 2016). doi:10.1038/eye.2016.96 Authors: J Moon, M Kim & M Sagong
Angle closure glaucoma in the Northern Ireland Diabetic Retinopathy Screening Programme – (Eye 30, 1091 (August 2016))
Angle closure glaucoma in the Northern Ireland Diabetic Retinopathy Screening Programme Eye 30, 1091 (August 2016). doi:10.1038/eye.2016.98 Authors: M A Lagan, M K O’Gallagher, S E Johnston & P M Hart
Clinical efficacy of modified partial pars plana vitrectomy combined with phacoemulsification for malignant glaucoma – (Eye 30, 1094 (August 2016))
Clinical efficacy of modified partial pars plana vitrectomy combined with phacoemulsification for malignant glaucoma Eye 30, 1094 (August 2016). doi:10.1038/eye.2016.106 Authors: F He, Z Qian, L Lu, J Jiang, X Fan, Z Wang & X Xu